GoldenGolden
Advanced Search
Stealth BioTherapeutics

Stealth BioTherapeutics

Stealth BioTherapeutics is a clinical-stage biotechnology company

Stealth BioTherapeutics is a clinical-stage biotechnology company focused on the discovery, development and commercialization of novel therapies for diseases involving genetic mutation resulting in mitochondrial dysfunction. The company is headquartered in Newton, Massachusettes and was founded in 2007 by Hazel Szeto.

Timeline

April 2020
Stealth BioTherapeutics raises a $20,000,001 venture round from Morningside Venture Capital.
June 2018
Stealth BioTherapeutics raises a $100,000,000 convertible note from Atlantis Investment Management, BVCF Management, CMBC Capital Holdings, Kingdon Capital, Morningside Venture Capital, Nan Fung Group, Ocean Equity Partners, Pivotal bioVenture Partners and Sagamore Investments.
2007
Stealth BioTherapeutics was founded by Hazel Szeto.

Funding rounds

People

Name
Role
LinkedIn

Further reading

Title
Author
Link
Type
Date

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

News

Title
Author
Date
Publisher
Description
Stealth BioTherapeutics Inc.
May 28, 2021
www.prnewswire.com:443
/PRNewswire/ -- Stealth BioTherapeutics Corp (Nasdaq: MITO), a clinical-stage biotechnology company focused on the discovery, development and commercialization...
Stealth BioTherapeutics Inc.
May 17, 2021
www.prnewswire.com:443
/PRNewswire/ -- Stealth BioTherapeutics Corp (Nasdaq: MITO), a clinical-stage biotechnology company focused on the discovery, development, and...
Stealth BioTherapeutics Inc.
May 17, 2021
www.prnewswire.com:443
/PRNewswire/ -- Stealth BioTherapeutics Corp (Nasdaq: MITO), a clinical-stage biotechnology company focused on the discovery, development, and...
Stealth BioTherapeutics Inc.
May 13, 2021
www.prnewswire.com:443
/PRNewswire/ -- Stealth BioTherapeutics Corp (Nasdaq: MITO), a clinical-stage biotechnology company focused on the discovery, development and commercialization...
Stealth BioTherapeutics Inc.
May 11, 2021
www.prnewswire.com:443
/PRNewswire/ -- Stealth BioTherapeutics Corp (Nasdaq: MITO), a clinical-stage biotechnology company focused on the discovery, development and commercialization...
Stealth BioTherapeutics Inc.
May 5, 2021
www.prnewswire.com:443
/PRNewswire/ -- Stealth BioTherapeutics Corp (Nasdaq: MITO), a clinical-stage biotechnology company focused on the discovery, development, and...
Stealth BioTherapeutics Inc.
April 28, 2021
www.prnewswire.com:443
/PRNewswire/ -- Stealth BioTherapeutics Corp (Nasdaq: MITO), a clinical-stage biotechnology company focused on the discovery, development, and...
Stealth BioTherapeutics Inc.
March 2, 2021
www.prnewswire.com:443
/PRNewswire/ -- Stealth BioTherapeutics Corp (Nasdaq: MITO), a clinical-stage biotechnology company focused on the discovery, development and commercialization...
Stealth BioTherapeutics Inc.
February 23, 2021
www.prnewswire.com:443
/PRNewswire/ -- Stealth BioTherapeutics Corp (Nasdaq: MITO), a clinical-stage biotechnology company focused on the discovery, development and commercialization...
Stealth BioTherapeutics Inc.
January 7, 2021
www.prnewswire.com:443
/PRNewswire/ -- Stealth BioTherapeutics Corp (Nasdaq: MITO), a clinical-stage biotechnology company focused on the discovery, development and commercialization...
Stealth BioTherapeutics Inc.
January 6, 2021
www.prnewswire.com:443
/PRNewswire/ -- Stealth BioTherapeutics Corp (Nasdaq: MITO), a clinical-stage biotechnology company focused on the discovery, development and commercialization...
Stealth BioTherapeutics Inc.
December 9, 2020
www.prnewswire.com:443
/PRNewswire/ -- Stealth BioTherapeutics Corp (Nasdaq: MITO), a clinical-stage biotechnology company focused on the discovery, development and commercialization...
Stealth BioTherapeutics Inc.
November 24, 2020
www.prnewswire.com:443
/PRNewswire/ -- Stealth BioTherapeutics Corp (Nasdaq: MITO) ("Stealth" or the "Company"), a clinical-stage biotechnology company focused on the discovery,...
Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.